The deadly lung disease related to gunfire could cause the United States and others to legalize marijuana, Tilray CEO Brendan Kennedy told CNBC Tuesday.
"All the products that we manufacture in Canada and produce worldwide are well tested by not only Health Canada but regulators in other countries," Kennedy told "Closing Bell." "The vaping crisis can be argued for more legalization. "
Health officials call the disease EVALI, an abbreviation for e-cigarette, or vaping, product use associated with lung injury. Most patients have reported vaping THC, the active ingredient in marijuana, according to the Centers for Disease Control and Prevention. Recent national and state findings indicate that products containing THC, especially those purchased from the street or from other informal sources, are linked to most cases, the CDC said.
To date, the CDC has confirmed 2,051
Canada is the first G-7 country to legalize recreational marijuana. Only 11 states in the United States and the District of Columbia have legalized recreational cannabis.
In recent months, marijuana advocates have renewed calls for legal and regulated marijuana amid the outbreak of gunfire. They say that regulating the drug will make people safer.
Kennedy appeared on CNBC just after Tilray reported financial results for the third quarter.
The Canadian pot manufacturer reported a loss of 36 cents on revenue of $ 51.1 million. The stock rose about 0.60% in trading on demand Tuesday.